Table 1.
Characteristics of Patients with Juvenile Idiopathic Arthritis and Uveitis
| Number of patients | 75 |
| Median age at diagnosis of uveitis, yr (range) | 7 (1-36) |
| Median age at diagnosis of arthritis, yr (range) | 5 (1-16) |
| Gender | |
| % female | 73.3 |
| % male | 26.7 |
| Race | |
| % white | 84.9 |
| % black | 6.9 |
| Median duration of arthritis prior to presentation, yr (range) | 10 (1 month-52) |
| Median duration of arthritis prior to diagnosis of uveitis, yr (range) | 1 (0-36) |
| Median duration of uveitis prior to presentation, yr (range) | 6 (1 month-48) |
| Bilateral uveitis, % | 70.7 |
| Type of JIA | |
| % Persistent oligoarticular (n) | 81.3 (61) |
| % Systemic | 1.3 (1) |
| % Polyarticular, RF negative | 6.7 (5) |
| % Polyarticular, RF positive | 5.3 (4) |
| % Enthesitis-related | 4.0 (3) |
| % Psoriatic arthritis | 1.3 (1) |
| Type of uveitis | |
| % Anterior uveitis | 86.7 |
| % Anterior and intermediate uveitis | 13.3 |
| % ANA positive | 69.7 |
| Median ANA titer (range) | 1:160 (1:10 - 1:640) |
| Therapies prior to presentation | |
| Oral corticosteroids, % | 35.1 |
| Methotrexate, % | 18.7 |
| Cyclosporine, % | 4.0 |
| Periocular corticosteroid injection, % | 18.7 |
| Therapies at presentation | |
| Oral corticosteroids, % | 12.0 |
| Methotrexate, % | 16.0 |
| Cyclosporine, % | 2.7 |
| Visual acuity, % | |
| Better eye, 20/50 or worse | 18.7 |
| Better eye, 20/200 or worse | 12.0 |
| Eye-specific characteristics | |
| Number of affected eyes | 132 |
| Ocular findings at presentation, % | |
| Band keratopathy | 31.5 |
| Posterior synechiae | 27.5 |
| Cataract | 22.5 |
| Aphakic | 17.0 |
| Pseudophakic | 6.1 |
| Keratic precipitates | 15.4 |
| Macular edema | 3.0 |
| Epiretinal membrane | 3.8 |
| Optic nerve edema | 4.5 |
| Anterior chamber cell (≥ 0.5+) | 44.3 |
| Anterior chamber flare (≥ 1+) | 49.0 |
| Vitreous cell (≥ 0.5+) | 23.2 |
| Ocular hypertension | 15.3 |
| Hyptony | 9.3 |
| Visual acuity at presentation, affected eyes, % | |
| 20/50 or worse | 36.4 |
| 20/200 or worse | 23.7 |
| Surgeries prior to presentation | |
| Cataract extraction | 26.7 |
| YAG laser capsulotomy | 1.3 |
| Band keratopathy chelation | 5.3 |
| Trabeculectomy | 2.6 |
| Tube shunt placement | 0.7 |
| Laser peripheral iriditomy | 1.3 |
| Vitrectomy | 7.3 |
ANA = antinuclear antibody; JIA = juvenile idiopathic arthritis; yr = years; (n) = number of patients with characteristic; (n/N) = number of eyes with characteristic/number of eyes at risk